Xenetic Biosciences- Warrants (19/07/2024) Other Current Liabilities

As of the most recent data (June 2026), XBIOW shows a other current liabilities of $570K. That compares with $560K in the prior-year period — up 2.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XBIOW's other current liabilities is now $570K (was $560K) — a 2.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Xenetic Biosciences- Warrants (19/07/2024) is outperforming or lagging.

Tracking XBIOW's other current liabilities over time shows whether Xenetic Biosciences- Warrants (19/07/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $570K That compares with $560K in the prior-year period — up 2.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Xenetic Biosciences- Warrants (19/07/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $570K) with ownership activity and broader fundamentals.

Xenetic Biosciences- Warrants (19/07/2024)'s other current liabilities is $570K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.